Emmanuel S. Antonarakis

2009–2026 年に発表

別表記
Emmanuel S Antonarakis
238
論文数
31,157
被引用数
83
h 指数
217
i10 指数

被引用数

Emmanuel S. Antonarakis の年別被引用数1998 年: 被引用 2 件2004 年: 被引用 1 件2006 年: 被引用 1 件2008 年: 被引用 1 件2009 年: 被引用 4 件2010 年: 被引用 1 件2011 年: 被引用 15 件2012 年: 被引用 14 件2013 年: 被引用 32 件2014 年: 被引用 79 件2015 年: 被引用 230 件2016 年: 被引用 325 件2017 年: 被引用 379 件2018 年: 被引用 406 件2019 年: 被引用 1,389 件2020 年: 被引用 1,786 件2021 年: 被引用 2,031 件2022 年: 被引用 1,476 件2023 年: 被引用 1,113 件2024 年: 被引用 1,919 件2025 年: 被引用 903 件2026 年: 被引用 23 件1999〜2003 年は被引用が無いため表示していません2005 年は被引用が無いため表示していません2007 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,804 件、この内訳の 25.2%中国: 引用元論文 1,532 件、この内訳の 10.2%イギリス: 引用元論文 899 件、この内訳の 6%イタリア: 引用元論文 881 件、この内訳の 5.8%ドイツ: 引用元論文 871 件、この内訳の 5.8%カナダ: 引用元論文 644 件、この内訳の 4.3%オーストラリア: 引用元論文 566 件、この内訳の 3.7%フランス: 引用元論文 498 件、この内訳の 3.3%スペイン: 引用元論文 487 件、この内訳の 3.2%オランダ: 引用元論文 422 件、この内訳の 2.8%日本: 引用元論文 393 件、この内訳の 2.6%スイス: 引用元論文 363 件、この内訳の 2.4%
0%25.2%その他 24.7%

分野

  • Medicine62%
  • Biochemistry, Genetics and Molecular Biology31.5%
  • Immunology and Microbiology2.4%
  • Engineering1%
  • Computer Science0.6%
  • Materials Science0.5%
  • その他2%

トピック

  • Prostate Cancer Treatment and Research13.4%
  • Cancer Genomics and Diagnostics8.6%
  • Prostate Cancer Diagnosis and Treatment7.1%
  • Radiopharmaceutical Chemistry and Applications3.7%
  • Cancer Immunotherapy and Biomarkers3%
  • Cancer Cells and Metastasis2.7%
  • その他61.5%

共著者

全論文

検索で開く
  1. Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Calogero Lauricella, Michael Lim, Evan J. Lipson, Suely Kazue Nagahashi Marie, George J. Netto, Kelly S. Oliner, Alessandro Olivi, Louise Olsson, Gregory J. Riggins, Andrea Sartore‐Bianchi, Kerstin Schmidt, le-Ming Shih, Sueli Mieko Oba‐Shinjo, Salvatore Siena, Dan Theodorescu, Jeanne Tie, Timothy T. Harkins, Silvio Veronese, Tian‐Li Wang, Jon Weingart, Christopher L. Wolfgang, Laura D. Wood, Dongmei Xing, Ralph H. Hruban, Jian Wu, Peter J. Allen, C. Max Schmidt, Michael A. Choti, Victor E. Velculescu, Kenneth W. Kinzler, Bert Vogelstein, Nickolas Papadopoulos, Luis A. Díaz - Science Translational Medicine 2014 被引用: 5,110

  2. Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter S. Nelson, Lawrence H. Schwartz, Susan Halabi, Philip W. Kantoff, Andrew J. Armstrong - Journal of Clinical Oncology 2016 被引用: 1,603

  3. AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 被引用: 2,687

  4. Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2020 被引用: 1,140

  5. Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 706

  6. NCCN Guidelines Insights: Prostate Cancer, Version 1.2021

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dorothy A. Shead, Deborah A. Freedman-Cass - Journal of the National Comprehensive Cancer Network 2021 被引用: 530

  7. Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Ross Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Dan George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raja Leibowitz, Christopher Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Amee Morgans, Michael J. Morris, Hind M’rabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki ほか 18 名 - European Journal of Cancer 2023 被引用: 157

  8. Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jonathan D. Tward, Dorothy A. Shead, Deborah A. Freedman-Cass - Journal of the National Comprehensive Cancer Network 2019 被引用: 1,573

  9. Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maximillian Diehn, Søren M. Bentzen, Steven Joniau, Friedl Vanhaverbeke, Gert De Meerleer, Emmanuel S. Antonarakis, Tamara L. Lotan, Alejandro Berlín, Shankar Siva, Piet Ost, Phuoc T. Tran - Journal of Clinical Oncology 2022 被引用: 243

  10. Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Evan Y. Yu - Journal of Clinical Oncology 2023 被引用: 132

  11. Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2023 被引用: 103

  12. Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 364

  13. Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2020 被引用: 176

  14. Familial Clonal Hematopoiesis in a Long Telomere Syndrome

    著者: , , , , , , , , , , , , - New England Journal of Medicine 2023 被引用: 143

  15. CDK12-Altered Prostate Cancer: Clinical Features and Therapeutic Outcomes to Standard Systemic Therapies, Poly (ADP-Ribose) Polymerase Inhibitors, and PD-1 Inhibitors

    著者: , , , , , , , , , , , , , , , , , , - JCO Precision Oncology 2020 被引用: 206

  16. Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology

    著者: , , , , , , , , , - European Urology 2018 被引用: 446

  17. Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Rosalind A. Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Daniel J. George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia S. Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raya Leibowitz‐Amit, Christopher J. Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Alicia K. Morgans, Michael J. Morris, Hind M’rabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver A. Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki ほか 18 名 - European Urology 2022 被引用: 118

  18. Sipuleucel-T for the Treatment of Prostate Cancer: Novel Insights and Future Directions

    著者: , - Future Oncology 2017 被引用: 176

  19. Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide

    著者: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 被引用: 472

  20. T-Cell Infiltration and Adaptive Treg Resistance in Response to Androgen Deprivation With or Without Vaccination in Localized Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2020 被引用: 114

  21. SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis–Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate Cancer

    著者: , , , , , , , , , , , , , - Clinical Cancer Research 2022 被引用: 68

  22. Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer

    著者: , , , , , , , , , , , - JAMA Oncology 2015 被引用: 616

  23. Initial Evaluation of [18F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer

    著者: , , , , , , , , , , , , , , , - Molecular Imaging and Biology 2015 被引用: 448

  24. Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies

    著者: , , , , , , , - Prostate Cancer and Prostatic Diseases 2018 被引用: 146